Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.

Cimino-Mathews A, Subhawong AP, Elwood H, Warzecha HN, Sharma R, Park BH, Taube JM, Illei PB, Argani P.

Hum Pathol. 2013 Jun;44(6):959-65. doi: 10.1016/j.humpath.2012.09.005. Epub 2012 Dec 20.

2.

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.

Cimino-Mathews A, Subhawong AP, Illei PB, Sharma R, Halushka MK, Vang R, Fetting JH, Park BH, Argani P.

Hum Pathol. 2013 Jul;44(7):1341-9. doi: 10.1016/j.humpath.2012.11.003. Epub 2013 Jan 31.

3.
5.

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.

Reis-Filho JS, Steele D, Di Palma S, Jones RL, Savage K, James M, Milanezi F, Schmitt FC, Ashworth A.

Mod Pathol. 2006 Feb;19(2):307-19.

6.

[Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].

Yang G, Guo L, Jin H, Li J, Ding H.

Zhonghua Bing Li Xue Za Zhi. 2014 Jul;43(7):437-41. Chinese.

PMID:
25327790
7.

Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.

Merkin RD, Vanner EA, Romeiser JL, Shroyer ALW, Escobar-Hoyos LF, Li J, Powers RS, Burke S, Shroyer KR.

Hum Pathol. 2017 Apr;62:23-32. doi: 10.1016/j.humpath.2016.10.006. Epub 2016 Nov 2.

PMID:
27816721
8.

Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.

Popnikolov NK, Cavone SM, Schultz PM, Garcia FU.

Mod Pathol. 2005 Dec;18(12):1535-41.

9.

Identification of a basal-like subtype of breast ductal carcinoma in situ.

Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.

Hum Pathol. 2007 Feb;38(2):197-204.

PMID:
17234468
10.

NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas.

Asch-Kendrick RJ, Samols MA, Lilo MT, Subhawong AP, Sharma R, Illei PB, Argani P, Cimino-Mathews A.

J Clin Pathol. 2014 Sep;67(9):768-71.

11.

Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.

Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P.

Hum Pathol. 2008 Mar;39(3):386-92. doi: 10.1016/j.humpath.2007.07.007. Epub 2008 Jan 9.

PMID:
18187183
12.

Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.

Pomp V, Leo C, Mauracher A, Korol D, Guo W, Varga Z.

Breast Cancer Res Treat. 2015 Nov;154(1):45-55.

PMID:
26467042
13.

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.

Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM.

Mod Pathol. 2011 Jul;24(7):924-31. doi: 10.1038/modpathol.2011.54. Epub 2011 May 6.

14.

[ErbB-2 expression and hormone receptor status in areas of transition from in situ to invasive ductal breast carcinoma].

Peres RM, Derchain SF, Heinrich JK, Serra KP, Pinto GA, Soares FA, Sarian LO.

Rev Bras Ginecol Obstet. 2009 Sep;31(9):461-7. Portuguese.

15.

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.

Dabbs DJ, Chivukula M, Carter G, Bhargava R.

Mod Pathol. 2006 Nov;19(11):1506-11. Epub 2006 Aug 25.

16.

Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.

PMID:
18300793
17.

Molecular phenotypes of DCIS predict overall and invasive recurrence.

Williams KE, Barnes NL, Cramer A, Johnson R, Cheema K, Morris J, Howe M, Bundred NJ.

Ann Oncol. 2015 May;26(5):1019-25. doi: 10.1093/annonc/mdv062. Epub 2015 Feb 12.

PMID:
25678586
18.

Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.

Miettinen M, McCue PA, Sarlomo-Rikala M, Biernat W, Czapiewski P, Kopczynski J, Thompson LD, Lasota J, Wang Z, Fetsch JF.

Am J Surg Pathol. 2015 Jun;39(6):826-35. doi: 10.1097/PAS.0000000000000398.

19.

Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor-product relationship.

Thike AA, Iqbal J, Cheok PY, Tse GM, Tan PH.

J Clin Pathol. 2013 Aug;66(8):665-70. doi: 10.1136/jclinpath-2012-201428. Epub 2013 Mar 28.

PMID:
23539741
20.

Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.

Song Y, Liu X, Zhang G, Song H, Ren Y, He X, Wang Y, Zhang J, Zhang Y, Sun S, Liang X, Sun Q, Pang D.

World J Surg Oncol. 2013 Jun 6;11:129. doi: 10.1186/1477-7819-11-129.

Supplemental Content

Support Center